Universal antenatal screening for group B streptococcus may cause more harm than good.
journal contribution
posted on 2019-06-14, 12:31 authored by F Seedat, J Geppert, C Stinton, J Patterson, K Freeman, SA Johnson, H Fraser, CS Brown, OA Uthman, B Tan, ER Robinson, ND McCarthy, A Clarke, J Marshall, C Visintin, A Mackie, S Taylor-PhillipsBased on current evidence, routine screening for group B streptococcus colonisation in late pregnancy
should not be introduced in the UK, as the potential harms of unnecessary treatment with antibiotics
may outweigh the benefits, argue Farah Seedat and colleagues
Funding
The research underpinning this analysis article was commissioned by the UK National Screening Committee (NSC). ST-P, CS, HF, JG, and AC are supported by the National Institute for Health Research CLAHRC West Midlands initiative. ST-P is supported by an NIHR Career Development Fellowship.
History
Citation
BMJ, 2019, 364:l463Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Cardiovascular SciencesVersion
- VoR (Version of Record)
Published in
BMJPublisher
BMJ Publishing Groupeissn
1756-1833Copyright date
2019Available date
2019-06-14Publisher DOI
Publisher version
https://www.bmj.com/content/364/bmj.l463Language
enAdministrator link
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC